Reforming Drug Pricing: A Call for Fairness

This chapter examines the disparities in pharmaceutical pricing between the United States and other countries, emphasizing the unfair burden placed on American consumers. It discusses proposed reforms aimed at reducing drug costs by adopting lower price strategies and addressing the influence of middlemen. The speakers advocate for a more equitable healthcare system that benefits U.S. patients while holding foreign entities accountable for inflated pricing.